The Management of Permanent Primary Hypoparathyroidism in Children and Adolescents: A Complex Task.

The Management of Permanent Primary Hypoparathyroidism in Children and Adolescents: A Complex Task.
Pediatr Endocrinol Rev. 2018 Sep;16(1):194-202
Authors: De Sanctis V, Soliman AT, Di Maio S, Kattamis C
Abstract
Management of hypoparathyroidism (hypoPT), depends on the etiology and the severity of hypocalcemia. Treatment goals include control of hypocalcemic symptoms preserving serum calcium in the low-normal range and phosphate in the high normal range. While correction of serum calcium to low-normal range does not fully correct mineral and bone metabolism it may be associated with increased risk of complications such as nephrolithiasis, nephrocalcinosis and soft tissue calcifications. Therefore, it is imperative to find out ways to individualize treatment of patients with hypoPT to achieve the best prognosis while minimizing complications. Replacement therapy with recombinant human PTH (rhPTH) was recently tested for optimizing treatment of hypoPT in a small number of patients. For children and adolescents, further studies are needed to evaluate the long-term effects and safety of rhPTH. In this short review we summarize current knowledge on the management of hypoPT and debate our gaps on the long-term management of children and adolescents with hypoPT.
PMID: 30371038 [PubMed - in process]

Source: Pediatric Endocrinology Reviews - October 31, 2018 Category: Endocrinology Tags: Pediatr Endocrinol Rev Source Type: research